Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Clinical trial NCT03513406 · COMPLETED
Trial details
- NCT number
- NCT03513406
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2023-03-07
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.